Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biovie Inc

Current price
0.45 USD -0.007 USD (-1.53%)
Last closed 0.45 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 27 527 864 USD
Yield for 12 month -91.82 %
21.11.2021 - 28.11.2021

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. Address: 680 West Nye Lane, Carson City, NV, United States, 89703

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

11 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-266 842 USD

Last Year

-237 421 USD

Current Quarter

-57 344 USD

Last Quarter

-57 344 USD

Key Figures BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -38 136 700 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -62.32 %
PEG Ratio
Return On Equity TTM -178.58 %
Wall Street Target Price 11 USD
Revenue TTM
Book Value 0.31 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.93 USD
Diluted Eps TTM -0.93 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BIVI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:125
Payout Ratio
Last Split Date 22.11.2019
Dividend Date 22.11.2019

Stock Valuation BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -11.6556
Price Book MRQ 1.4632

Financials BIVI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIVI

For 52 weeks

0.43 USD 6.45 USD
50 Day MA 0.51 USD
Shares Short Prior Month 1 272 318
200 Day MA 1.96 USD
Short Ratio 1.98
Shares Short 1 089 737
Short Percent 2.91 %

Dynamics of changes in the value of assets




430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds



14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics